Torsemide Fast Dissolving Tablets: Development, Optimization Using Box–Bhenken Design and Response Surface Methodology, In Vitro Characterization, and Pharmacokinetic Assessment
Autor: | Heba F. Mansour, Mahmoud M. Ahmed, Ahmed A El-Shenawy, Saleh Abd El Rasoul |
---|---|
Rok vydání: | 2017 |
Předmět: |
Materials science
Drug Compounding Biological Availability Pharmaceutical Science Excipient 02 engineering and technology Aquatic Science Friability 030226 pharmacology & pharmacy Excipients 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Spectroscopy Fourier Transform Infrared Drug Discovery Pharmaceutic Aids medicine Animals Sorbitol Response surface methodology Antihypertensive Agents Ecology Evolution Behavior and Systematics Croscarmellose sodium Sulfonamides Chromatography Calorimetry Differential Scanning Ecology Polyvinylpyrrolidone Povidone Torsemide General Medicine Factorial experiment 021001 nanoscience & nanotechnology Bioavailability Solubility chemistry Carboxymethylcellulose Sodium Sweetening Agents Rabbits 0210 nano-technology Agronomy and Crop Science Tablets medicine.drug |
Zdroj: | AAPS PharmSciTech. 18:2168-2179 |
ISSN: | 1530-9932 |
DOI: | 10.1208/s12249-016-0697-6 |
Popis: | The present study planed to develop new fast dissolving tablets (FDTs) of torsemide. Solid dispersions (SDs) of torsemide and sorbitol (3:1) or polyvinylpyrrolidone (PVP) k25 were prepared. The prepared SDs were evaluated for in-vitro dissolution. Fourier transform infrared spectroscopy and differential scanning calorimetry for SDs revealed no drug/excipient interactions and transformation of torsemide to the amorphous form. Torsemide/sorbitol SD was selected for formulation of torsemide FDTs by direct compression method. Box-Bhenken factorial design was employed to design 15 formulations using croscarmellose sodium and crospovidone at different concentrations. The response surface methodology was used to analyze the effect of changing these concentrations (independent variables) on disintegration time (Y1), percentage friability (Y2), and amount torsemide released at 10 min. The physical mixtures of torsemide and the used excipients were evaluated for angle of repose, Hausner's ratio, and Carr's index. The prepared FDTs tablets were evaluated for wetting and disintegration time, weight variation, drug content, percentage friability, thickness, hardness, and in vitro release. Based on the in-vitro results and factorial design characterization, F10 and F7 were selected for bioavailability studies following administration to Albino New Zealand rabbits. They showed significantly higher C max and (AUC0-12) and shorter T max than those obtained after administration of the corresponding ordinary commercial Torseretic ® tablets. Stability study was conducted for F10 that showed good stability upon storage at 30°C/75% RH and 40°C/75% RH for 3 months. |
Databáze: | OpenAIRE |
Externí odkaz: |